These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1833045)
1. The use of a panel of monoclonal antibodies can lower false-negative diagnoses of peritoneal washings in ovarian tumors. Mottolese M; Salzano M; Vincenzoni C; Benevolo M; Bigotti A; Iacovelli A; Lombardi A; Atlante G; Natali PG Cancer; 1991 Oct; 68(8):1803-7. PubMed ID: 1833045 [TBL] [Abstract][Full Text] [Related]
2. Use of immunocytochemical staining to identify cells in peritoneal fluid and washings at laparoscopy and laparotomy. Ghosh AK; Spriggs AI; Charnock M J Clin Pathol; 1986 Dec; 39(12):1335-9. PubMed ID: 2948971 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity enhancement of the cytologic detection of cancer cells in effusions by monoclonal antibodies. Ménard S; Rilke F; Della Torre G; Mariani-Costantini R; Regazzoni M; Tagliabue E; Alasio L; Colnaghi MI Am J Clin Pathol; 1985 May; 83(5):571-6. PubMed ID: 3887893 [TBL] [Abstract][Full Text] [Related]
4. Peritoneal washings in ovarian tumors. Potential sources of error in cytologic diagnosis. Covell JL; Carry JB; Feldman PS Acta Cytol; 1985; 29(3):310-6. PubMed ID: 3859128 [TBL] [Abstract][Full Text] [Related]
5. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma. Littell RD; Hallonquist H; Matulonis U; Seiden MV; Berkowitz RS; Duska LR Gynecol Oncol; 2006 Nov; 103(2):570-4. PubMed ID: 16769104 [TBL] [Abstract][Full Text] [Related]
6. [Reliability of cytodiagnosis from washings and free fluid in the staging and follow-up of ovarian tumors]. Ciarmiello G; Sopracordevole F; Miotto E; Scarabelli C Minerva Ginecol; 1990; 42(1-2):11-4. PubMed ID: 2139923 [TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical detection of ovarian carcinoma cells in serous effusions. Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129 [TBL] [Abstract][Full Text] [Related]
9. Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms. Harłozińska A; Bar JK; Cisło M; Richter R; Rabczyński J Anal Cell Pathol; 1992 Jan; 4(1):1-12. PubMed ID: 1370907 [TBL] [Abstract][Full Text] [Related]
10. Detection of adenocarcinoma in peritoneal washings by staining with monoclonal antibody B72.3. Szpak CA; Soper JT; Thor A; Schlom J; Johnston WW Acta Cytol; 1989; 33(2):205-14. PubMed ID: 2648721 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of second-look laparotomy for patients with epithelial ovarian carcinoma. Kamura T; Tsukamoto N; Saito T; Kaku T; Matsuyama T; Nakano H Int J Gynaecol Obstet; 1990 Oct; 33(2):141-7. PubMed ID: 1976547 [TBL] [Abstract][Full Text] [Related]
12. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma. Rubin SC; Dulaney ED; Markman M; Hoskins WJ; Saigo PE; Lewis JL Obstet Gynecol; 1988 Jun; 71(6 Pt 1):851-3. PubMed ID: 3285264 [TBL] [Abstract][Full Text] [Related]
13. Cytologic smears of peritoneal surfaces as a sampling technique in epithelial ovarian carcinoma. Jadhon ME; Morgan MA; Kelsten ML; Carlson JA; Mikuta JJ Obstet Gynecol; 1990 Jan; 75(1):102-5. PubMed ID: 2296407 [TBL] [Abstract][Full Text] [Related]
14. [Detection of cancer cells in peritoneal fluid or washing by immunocytochemical staining with monoclonal antibodies]. Zhao Y Zhonghua Fu Chan Ke Za Zhi; 1992 May; 27(3):159-61, 189. PubMed ID: 1382925 [TBL] [Abstract][Full Text] [Related]
15. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3. Martin SE; Moshiri S; Thor A; Vilasi V; Chu EW; Schlom J Am J Clin Pathol; 1986 Jul; 86(1):10-8. PubMed ID: 3524191 [TBL] [Abstract][Full Text] [Related]
16. Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma. Na K; Lee JY; Sung JY; Kim GM; Koo JS; Kim HS Virchows Arch; 2018 Aug; 473(2):165-175. PubMed ID: 29926183 [TBL] [Abstract][Full Text] [Related]
17. Value of peritoneal cytology after hysteroscopy in surgical stage I adenocarcinoma of the endometrium. Leveque J; Goyat F; Dugast J; Loeillet L; Grall JY; Le Bars S Oncol Rep; 1998; 5(3):713-5. PubMed ID: 9538182 [TBL] [Abstract][Full Text] [Related]
18. Correlation of serum and ascitic IL-12 levels with second-look laparotomy results and disease progression in advanced epithelial ovarian cancer patients. Bozkurt N; Yuce K; Basaran M; Gariboglu S; Kose F; Ayhan A Int J Gynecol Cancer; 2006; 16(1):83-6. PubMed ID: 16445615 [TBL] [Abstract][Full Text] [Related]
19. Concordance of Expert Consultation Diagnoses in the Review of Pelvic Washing Specimens. Banet N; Levinson KL; VandenBussche CJ Acta Cytol; 2015; 59(6):452-6. PubMed ID: 26820245 [TBL] [Abstract][Full Text] [Related]
20. Value of peritoneal lavage cytology during laparoscopic staging of patients with gastric carcinoma. Ribeiro U; Gama-Rodrigues JJ; Bitelman B; Ibrahim RE; Safatle-Ribeiro AV; Laudanna AA; Pinotti HW Surg Laparosc Endosc; 1998 Apr; 8(2):132-5. PubMed ID: 9566568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]